![]() | Up a level |
Macbeth, Fergus, Noble, Simon, Evans, Jessica, Ahmed, Sheikh, Cohen, David, Hood, Kerenza, Knoyle, Dana, Linnane, Seamus, Longo, Mirella, Moore, Barbara, Woll, Penella J., Appel, Wiebke, Dickson, Jeanette, Ferry, David, Brammer, Caroline and Griffiths, Gareth 2016. Randomized phase III trial of standard therapy plus low molecular weight heparin in patients with lung cancer: FRAGMATIC trial. Journal of Clinical Oncology 34 (5) , pp. 488-494. 10.1200/JCO.2015.64.0268 |
![]() |
Noble, Simon I., Nelson, Annmarie, Fitzmaurice, David, Bekkers, Marie-Jet, Baillie, Jessica, Sivell, Stephanie, Canham, Joanna, Smith, Joanna D., Casbard, Angela, Cohen, Ander, Cohen, David, Evans, Jessica, Fletcher, Kate, Johnson, Miriam, Maraveyas, Anthony, Prout, Hayley and Hood, Kerenza 2015. A feasibility study to inform the design of a randomised controlled trial to identify the most clinically effective and cost-effective length of Anticoagulation with Low-molecular-weight heparin In the treatment of Cancer-Associated Thrombosis (ALICAT). Health Technology Assessment 19 (83) , pp. 1-93. 10.3310/hta19830 |
|
Geldart, Thomas, Chester, John, Casbard, Angela, Crabb, Simon, Elliott, Tony, Protheroe, Andrew, Huddart, Robert A., Mead, Graham, Barber, Jim, Jones, Robert J., Smith, Joanna, Cowles, Robert, Evans, Jessica and Griffiths, Gareth
2015.
SUCCINCT: an open-label, single-arm, non-randomised, phase 2 trial of gemcitabine and cisplatin chemotherapy in combination with sunitinib as first-line treatment for patients with advanced urothelial carcinoma.
European Urology
67
(4)
, pp. 599-602.
10.1016/j.eururo.2014.11.003
![]() |
|